Pseudopodial and β-arrestin-interacting proteomes from migrating breast cancer cells upon PAR2 activation

Journal of Proteomics

Volumn 80, Issue , 2013, Pages 91-106

  Parisis, Nikolaos ^a,b,c   Metodieva, Gergana ^a   Metodiev, Metodi V ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

^b CNRS   (France)

^c CEMAGREF   (France)

Author keywords

Beta arrestin; Cell migration; PAR 2; Proteomics; Pseudopodium

Indexed keywords

BETA ARRESTIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE ACTIVATED RECEPTOR 2; PROTEOME; CLATHRIN; HEAT SHOCK PROTEIN 70; NUCLEAR PROTEIN; NUCLEOPHOSMIN; RETINA S ANTIGEN;

ARTICLE; BREAST CANCER; CELL MIGRATION; ENDOCYTOSIS; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PSEUDOPODIUM; RADIOIMMUNOPRECIPITATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOLOGY; BREAST TUMOR; CELL MOTION; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELL LINE; IMMUNOPRECIPITATION; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; PROCEDURES; PROTEOMICS; TUMOR CELL LINE;

ARRESTINS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CLATHRIN; COMPUTATIONAL BIOLOGY; ENDOCYTOSIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MCF-7 CELLS; NUCLEAR PROTEINS; PROTEOME; PROTEOMICS; PSEUDOPODIA; RECEPTOR, PAR-2; SIGNAL TRANSDUCTION;

EID: 84873640501     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.12.024     Document Type: Article

References (57)

1. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., et al. Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709.
2. Devreotes P., Janetopoulos C. Eukaryotic chemotaxis: distinctions between directional sensing and polarization. J Biol Chem 2003, 278:20445-20448.
3. Chodniewicz D., Klemke R.L. Guiding cell migration through directed extension and stabilization of pseudopodia. Exp Cell Res 2004, 301:31-37.
4. Wang Y., Ding S.J., Wang W., Jacobs J.M., Qian W.J., Moore R.J., et al. Profiling signaling polarity in chemotactic cells. Proc Natl Acad Sci U S A 2007, 104:8328-8333.
5. Wang Y., Kelber J.A., Tran Cao H.S., Cantin G.T., Lin R., Wang W., et al. Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected]. Proc Natl Acad Sci U S A 2010, 107:10920-10925.
6. Nystedt S., Emilsson K., Larsson A.K., Strombeck B., Sundelin J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem 1995, 232:84-89.
7. Dery O., Corvera C.U., Steinhoff M., Bunnett N.W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 1998, 274:C1429-C1452.
8. Ramachandran R., Noorbakhsh F., Defea K., Hollenberg M.D. Targeting proteinase-activated receptors: therapeutic potential and challenges. Nat Rev Drug Discov 2012, 11:69-86.
9. D'Andrea M.R., Derian C.K., Santulli R.J., Andrade-Gordon P. Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues. Am J Pathol 2001, 158:2031-2041.
10. Ge L., Shenoy S.K., Lefkowitz R.J., DeFea K. Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. J Biol Chem 2004, 279:55419-55424.
11. Ikeda O., Egami H., Ishiko T., Ishikawa S., Kamohara H., Hidaka H., et al. Signal of proteinase-activated receptor-2 contributes to highly malignant potential of human pancreatic cancer by up-regulation of interleukin-8 release. Int J Oncol 2006, 28:939-946.
12. Shi X., Gangadharan B., Brass L.F., Ruf W., Mueller B.M. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2004, 2:395-402.
13. Hjortoe G.M., Petersen L.C., Albrektsen T., Sorensen B.B., Norby P.L., Mandal S.K., et al. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 2004, 103:3029-3037.
14. Kamath L., Meydani A., Foss F., Kuliopulos A. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells. Cancer Res 2001, 61:5933-5940.
15. Morris D.R., Ding Y., Ricks T.K., Gullapalli A., Wolfe B.L., Trejo J. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res 2006, 66:307-314.
16. Krupnick J.G., Benovic J.L. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 1998, 38:289-319.
17. Ossovskaya V.S., Bunnett N.W. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004, 84:579-621.
18. DeFea K.A., Zalevsky J., Thoma M.S., Dery O., Mullins R.D., Bunnett N.W. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 2000, 148:1267-1281.
19. Ge L., Ly Y., Hollenberg M., DeFea K. A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J Biol Chem 2003, 278:34418-34426.
20. Alldridge L., Metodieva G., Greenwood C., Al-Janabi K., Thwaites L., Sauven P., et al. Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry. J Proteome Res 2008, 7:1458-1469.
21. Greenwood C., Metodieva G., Al-Janabi K., Lausen B., Alldridge L., Leng L., et al. Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer. J Proteomics 2012, 75:3031-3040.
22. Laporte S.A., Oakley R.H., Zhang J., Holt J.A., Ferguson S.S., Caron M.G., et al. The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci U S A 1999, 96:3712-3717.
23. Luttrell L.M., Ferguson S.S., Daaka Y., Miller W.E., Maudsley S., Della Rocca G.J., et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 1999, 283:655-661.
24. Blackhart B.D., Emilsson K., Nguyen D., Teng W., Martelli A.J., Nystedt S., et al. Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem 1996, 271:16466-16471.
25. Compton S.J., Cairns J.A., Palmer K.J., Al-Ani B., Hollenberg M.D., Walls A.F. A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists. J Biol Chem 2000, 275:39207-39212.
26. Inoue H., Nojima H., Okayama H. High efficiency transformation of Escherichia coli with plasmids. Gene 1990, 96:23-28.
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
28. Mousseau Y., Leclers D., Faucher-Durand K., Cook-Moreau J., Lia-Baldini A.S., Rigaud M., et al. Improved agarose gel assay for quantification of growth factor-induced cell motility. Biotechniques 2007, 43:509-516.
29. Shevchenko A., Tomas H., Havlis J., Olsen J.V., Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006, 1:2856-2860.
30. Rauch A., Bellew M., Eng J., Fitzgibbon M., Holzman T., Hussey P., et al. Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. J Proteome Res 2006, 5:112-121.
31. Keller A., Eng J., Zhang N., Li X.J., Aebersold R. A uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol Syst Biol 2005, 1:0017.
32. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
33. Liu H., Sadygov R.G., Yates J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004, 76:4193-4201.
34. Thomas P.D., Kejariwal A., Campbell M.J., Mi H., Diemer K., Guo N., et al. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 2003, 31:334-341.
35. Calvano S.E., Xiao W., Richards D.R., Felciano R.M., Baker H.V., Cho R.J., et al. A network-based analysis of systemic inflammation in humans. Nature 2005, 437:1032-1037.
36. Brahmbhatt A.A., Klemke R.L. ERK and RhoA differentially regulate pseudopodia growth and retraction during chemotaxis. J Biol Chem 2003, 278:13016-13025.
37. Thompson E.W., Paik S., Brunner N., Sommers C.L., Zugmaier G., Clarke R., et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992, 150:534-544.
38. Eden E., Hammel J., Rouhani F.N., Brantly M.L., Barker A.F., Buist A.S., et al. Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest 2003, 123:765-771.
39. Beckner M.E., Chen X., An J., Day B.W., Pollack I.F. Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies. Lab Invest 2005, 85:316-327.
40. Thingholm T.E., Jensen O.N., Larsen M.R. Analytical strategies for phosphoproteomics. Proteomics 2009, 9:1451-1468.
41. Kubota Y., Ohkura K., Tamai K.K., Nagata K., Nishiwaki K. MIG-17/ADAMTS controls cell migration by recruiting nidogen to the basement membrane in C. elegans. Proc Natl Acad Sci U S A 2008, 105:20804-20809.
42. Baranowsky A., Mokkapati S., Bechtel M., Krugel J., Miosge N., Wickenhauser C., et al. Impaired wound healing in mice lacking the basement membrane protein nidogen 1. Matrix Biol 2008, 29:15-21.
43. Kuk C., Gunawardana C.G., Soosaipillai A., Kobayashi H., Li L., Zheng Y., et al. Nidogen-2: a new serum biomarker for ovarian cancer. Clin Biochem 2010, 43:355-361.
44. Vishnubhotla R., Sun S., Huq J., Bulic M., Ramesh A., Guzman G., et al. ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Lab Invest 2007, 87:1149-1158.
45. Xiao K., McClatchy D.B., Shukla A.K., Zhao Y., Chen M., Shenoy S.K., et al. Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc Natl Acad Sci U S A 2007, 104:12011-12016.
46. Lefkowitz R.J., Rajagopal K., Whalen E.J. New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol Cell 2006, 24:643-652.
47. Lefkowitz R.J., Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 2005, 308:512-517.
48. Min J., Defea K. beta-arrestin-dependent actin reorganization: bringing the right players together at the leading edge. Mol Pharmacol 2011, 80:760-768.
49. Lamaze C., Fujimoto L.M., Yin H.L., Schmid S.L. The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells. J Biol Chem 1997, 272:20332-20335.
50. Min J., Defea K. beta-arrestin-dependent actin reorganization: bringing the right players together at the leading edge. Mol Pharmacol 2011, 80:760-768.
51. Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, et al. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Res 72:604-15.
52. Colombo E., Alcalay M., Pelicci P.G. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases. Oncogene 2011, 30:2595-2609.
53. Okuwaki M. The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein. J Biochem 2008, 143:441-448.
54. Yung B.Y. Oncogenic role of nucleophosmin/B23. Chang Gung Med J 2007, 30:285-293.
55. Xu TR, Lu R.F., Romano D., Pitt A., Houslay M.D., Milligan G., et al. Eukaryotic translation initiation factor 3, subunit a, regulates the extracellular signal-regulated kinase pathway. Mol Cell Biol 2012, 32:88-95.
56. Yang L., Lin C., Liu Z.R. P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin. Cell 2006, 127:139-155.
57. Ulazzi L., Sabbioni S., Miotto E., Veronese A., Angusti A., Gafa R., et al. Nidogen 1 and 2 gene promoters are abberantly methylated in human gastointestinal cancer. Mol Cancer 2007, 6:17.